CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Agilon health, inc. - AGL CFD

    5.33
    7.89%
    0.11
    Low: 4.99
    High: 5.45
    Market Trading Hours* (UTC) Opens on Friday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.11
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 4.94
    Open* 5.05
    1-Year Change* -81.55%
    Day's Range* 4.99 - 5.45
    52 wk Range 14.36-28.36
    Average Volume (10 days) 1.68M
    Average Volume (3 months) 44.25M
    Market Cap 6.77B
    P/E Ratio -100.00K
    Shares Outstanding 411.86M
    Revenue 2.48B
    EPS -0.27
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Mar 1, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 17, 2024 4.94 0.52 11.76% 4.42 4.99 4.27
    Apr 16, 2024 4.42 -0.06 -1.34% 4.48 4.74 4.40
    Apr 15, 2024 4.40 -0.47 -9.65% 4.87 4.97 4.40
    Apr 12, 2024 4.89 -0.28 -5.42% 5.17 5.26 4.89
    Apr 11, 2024 5.27 -0.14 -2.59% 5.41 5.44 5.19
    Apr 10, 2024 5.35 0.07 1.33% 5.28 5.59 5.21
    Apr 9, 2024 5.50 0.40 7.84% 5.10 5.51 5.09
    Apr 8, 2024 5.13 0.46 9.85% 4.67 5.14 4.61
    Apr 5, 2024 4.69 0.01 0.21% 4.68 4.81 4.60
    Apr 4, 2024 4.79 0.12 2.57% 4.67 4.87 4.63
    Apr 3, 2024 4.69 -0.33 -6.57% 5.02 5.06 4.63
    Apr 2, 2024 5.02 -0.57 -10.20% 5.59 5.59 4.96
    Apr 1, 2024 5.79 -0.25 -4.14% 6.04 6.14 5.73
    Mar 28, 2024 6.05 0.44 7.84% 5.61 6.10 5.49
    Mar 27, 2024 5.69 0.69 13.80% 5.00 5.70 5.00
    Mar 26, 2024 4.94 0.26 5.56% 4.68 4.95 4.65
    Mar 25, 2024 4.72 -0.10 -2.07% 4.82 4.86 4.39
    Mar 22, 2024 4.83 -0.47 -8.87% 5.30 5.41 4.83
    Mar 21, 2024 5.38 -0.04 -0.74% 5.42 5.67 5.24
    Mar 20, 2024 5.47 0.17 3.21% 5.30 5.49 5.15

    Agilon health, inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total revenue 2708.21 1833.56 1218.33 794.411
    Revenue 2708.21 1833.56 1218.33 794.411
    Cost of Revenue, Total 2399.8 1647.66 1021.88 725.374
    Gross Profit 308.413 185.9 196.456 69.037
    Total Operating Expense 2834.1 2227.51 1275.01 900.985
    Selling/General/Admin. Expenses, Total 415.072 565.308 239.598 163.358
    Depreciation / Amortization 13.772 14.544 13.531 12.253
    Operating Income -125.889 -393.952 -56.673 -106.574
    Interest Income (Expense), Net Non-Operating -4.525 -6.146 -8.135 -9.068
    Other, Net 24.725 -4.5 2.465 0.955
    Net Income Before Taxes -105.689 -404.598 -62.343 -114.687
    Net Income After Taxes -107.329 -405.484 -63.208 -114.455
    Net Income Before Extra. Items -107.018 -405.184 -63.208 -114.455
    Total Extraordinary Items 0.465 -1.303 3.156 -168.133
    Net Income -106.553 -406.487 -60.052 -282.588
    Income Available to Common Excl. Extra. Items -107.018 -405.184 -63.208 -114.455
    Income Available to Common Incl. Extra. Items -106.553 -406.487 -60.052 -282.588
    Diluted Net Income -106.553 -406.487 -60.052 -282.588
    Diluted Weighted Average Shares 408.154 372.931 384.022 384.022
    Diluted EPS Excluding Extraordinary Items -0.2622 -1.08649 -0.16459 -0.29804
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -0.24957 -1.06331 -0.16459 -0.29804
    Minority Interest 0.311 0.3
    Unusual Expense (Income) 5.458
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 1149.05 1136.15 689.774 694.858 670.134
    Revenue 1149.05 1136.15 689.774 694.858 670.134
    Cost of Revenue, Total 1008.73 972.827 628.163 618.287 587.14
    Gross Profit 140.318 163.32 61.611 76.571 82.994
    Total Operating Expense 1178.87 1129.89 758.892 724.376 696.644
    Selling/General/Admin. Expenses, Total 164.624 152.87 126.822 102.639 101.004
    Depreciation / Amortization 5.515 4.189 3.907 3.45 3.042
    Operating Income -29.821 6.261 -69.118 -29.518 -26.51
    Interest Income (Expense), Net Non-Operating -1.588 -1.533 -1.709 -1 -0.945
    Other, Net 15.687 9.472 14.885 0.574 6.997
    Net Income Before Taxes -15.722 14.2 -55.942 -29.944 -20.458
    Net Income After Taxes -16.795 15.959 -56.514 -30.503 -21.038
    Minority Interest 0.046 0.063 0.083 0.071 0.082
    Net Income Before Extra. Items -16.749 16.022 -56.431 -30.432 -20.956
    Total Extraordinary Items 0 0 -0.035 -0.236 0.307
    Net Income -16.749 16.022 -56.466 -30.668 -20.649
    Income Available to Common Excl. Extra. Items -16.749 16.022 -56.431 -30.432 -20.956
    Income Available to Common Incl. Extra. Items -16.749 16.022 -56.466 -30.668 -20.649
    Diluted Net Income -16.749 16.022 -56.466 -30.668 -20.649
    Diluted Weighted Average Shares 410.338 426.586 412.147 411.065 407.339
    Diluted EPS Excluding Extraordinary Items -0.04082 0.03756 -0.13692 -0.07403 -0.05145
    Diluted Normalized EPS -0.04082 0.03785 -0.13692 -0.07322 -0.04233
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Unusual Expense (Income) 0 0 0 5.458
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Total Current Assets 1451.27 1367.19 294.197 245.528
    Cash and Short Term Investments 908.971 1040.04 106.795 123.633
    Cash & Equivalents 497.07 1040.04 106.795 123.633
    Total Receivables, Net 497.574 293.407 144.555 93.254
    Accounts Receivable - Trade, Net 497.574 293.407 144.555 93.254
    Prepaid Expenses 34.119 18.968 9.639 4.312
    Other Current Assets, Total 10.61 14.781 33.208 24.329
    Total Assets 1697.47 1586.25 446.361 402.794
    Property/Plant/Equipment, Total - Net 33.079 20.9 16.041 18.836
    Property/Plant/Equipment, Total - Gross 42.46 29.105 23.316 23.686
    Accumulated Depreciation, Total -9.381 -8.205 -7.275 -4.85
    Goodwill, Net 41.54 41.54 41.54 41.54
    Intangibles, Net 67.68 55.398 60.468 71.146
    Other Long Term Assets, Total 86.543 94.529 34.115 25.744
    Total Current Liabilities 535.091 356.96 266.835 199.61
    Payable/Accrued 183.364 112.946 97.244 67.555
    Notes Payable/Short Term Debt 0 0 0 0
    Current Port. of LT Debt/Capital Leases 5 5 3.041 3.041
    Other Current Liabilities, Total 346.727 239.014 166.55 129.014
    Total Liabilities 656.248 494.356 421.591 353.822
    Total Long Term Debt 38.482 43.401 64.665 67.143
    Long Term Debt 38.482 43.401 64.665 67.143
    Other Liabilities, Total 83.286 94.295 90.091 87.069
    Total Equity 1041.22 1091.9 24.77 48.972
    Common Stock 4.124 4.001 311.994 283.467
    Additional Paid-In Capital 2106.89 2045.57 263.966 256.643
    Retained Earnings (Accumulated Deficit) -1064.23 -957.677 -551.19 -491.138
    Total Liabilities & Shareholders’ Equity 1697.47 1586.25 446.361 402.794
    Total Common Shares Outstanding 412.385 400.095 384.022 384.022
    Long Term Investments 17.352 6.69
    Minority Interest -0.611 -0.3
    Short Term Investments 411.901
    Other Equity, Total -5.56
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1956.64 2044.84 1876.44 1451.27 1634.27
    Cash and Short Term Investments 564.217 580.027 816.682 908.971 959.28
    Cash & Equivalents 168.339 190.981 394.19 497.07 551.287
    Total Receivables, Net 1345.71 1417.05 1004.86 497.574 637.731
    Accounts Receivable - Trade, Net 1345.71 1417.05 1004.86 497.574 637.731
    Prepaid Expenses 36.512 37.56 44.697 34.119 24.067
    Other Current Assets, Total 10.204 10.204 10.204 10.61 13.192
    Total Assets 2278.07 2352.92 2170.27 1697.47 1870.44
    Property/Plant/Equipment, Total - Net 40.797 37.494 36.025 33.079 30.973
    Goodwill, Net 62.387 62.14 62.14 41.54 41.54
    Intangibles, Net 92.657 94.185 92.712 67.68 60.602
    Other Long Term Assets, Total 86.42 87.55 16.839 86.543 91.207
    Total Current Liabilities 1301.32 1362.35 972.609 535.091 658.226
    Payable/Accrued 290.563 257.819 222.052 183.364 162.386
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 5 5 5 5 5
    Other Current Liabilities, Total 1005.76 1099.53 745.557 346.727 490.84
    Total Liabilities 1405.71 1472.76 1087.76 656.248 784.618
    Total Long Term Debt 34.78 36.017 37.249 38.482 39.713
    Long Term Debt 34.78 36.017 37.249 38.482 39.713
    Minority Interest -0.767 -0.72 -0.674 -0.611 -0.528
    Other Liabilities, Total 70.37 75.106 78.571 83.286 87.207
    Total Equity 872.367 880.166 1082.51 1041.22 1085.82
    Common Stock 4.06 4.054 4.145 4.124 4.117
    Additional Paid-In Capital 1970.93 1947.44 2130.13 2106.89 2094.56
    Retained Earnings (Accumulated Deficit) -1096.39 -1064.96 -1048.21 -1064.23 -1007.76
    Total Liabilities & Shareholders’ Equity 2278.07 2352.92 2170.27 1697.47 1870.44
    Total Common Shares Outstanding 405.98 405.427 414.465 412.385 411.741
    Long Term Investments 39.17 26.709 20.518 17.352 11.843
    Short Term Investments 395.878 389.046 422.492 411.901 407.993
    Other Equity, Total -6.23 -6.369 -3.549 -5.56 -5.098
    Note Receivable - Long Term 65.596
    • Annual
    • Quarterly
    2022 2021 2020 2019
    Net income/Starting Line -106.864 -406.787 -60.052 -282.74
    Cash From Operating Activities -130.808 -148.159 -53.204 -103.861
    Cash From Operating Activities 13.772 14.67 14.099 41.413
    Deferred Taxes 0.532 -3.231 -2.809 -16.177
    Non-Cash Items 21.187 302.214 -10.914 120.466
    Cash Taxes Paid 5.313 1.819 0.002 0.026
    Cash Interest Paid 3.672 4.824 7.086 8.038
    Changes in Working Capital -59.435 -55.025 6.472 33.177
    Cash From Investing Activities -444.388 -90.506 22.066 -5.06
    Capital Expenditures -32.661 -13.426 -2.35 -3.906
    Other Investing Cash Flow Items, Total -411.727 -77.08 24.416 -1.154
    Cash From Financing Activities 28.056 1154.39 24.621 176.298
    Financing Cash Flow Items 0 -14.739 0 -0.303
    Issuance (Retirement) of Stock, Net 33.056 1189.03 27.662 180.193
    Issuance (Retirement) of Debt, Net -5 -19.899 -3.041 -3.592
    Net Change in Cash -547.14 915.725 -6.517 67.377
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 15.959 -106.864 -50.315 -19.576 1.155
    Cash From Operating Activities -60.811 -130.808 -80.849 -83.496 -23.233
    Cash From Operating Activities 4.189 13.772 9.865 6.415 3.373
    Deferred Taxes 0.532
    Non-Cash Items 10.511 21.187 19.218 6.233 2.493
    Cash Taxes Paid 0.171 5.313 4.223 0.566 3.098
    Cash Interest Paid 1.352 3.672 2.878 1.95 0.959
    Changes in Working Capital -91.47 -59.435 -59.617 -76.568 -30.254
    Cash From Investing Activities -50.814 -444.388 -436.418 -305.48 -8.869
    Capital Expenditures -3.717 -32.661 -24.352 -20.672 -5.049
    Other Investing Cash Flow Items, Total -47.097 -411.727 -412.066 -284.808 -3.82
    Cash From Financing Activities 8.339 28.056 26.926 17.815 13.506
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 9.589 33.056 30.676 20.315 14.756
    Issuance (Retirement) of Debt, Net -1.25 -5 -3.75 -2.5 -1.25
    Net Change in Cash -103.286 -547.14 -490.341 -371.161 -18.596

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Agilon Health Company profile

    Agilon Health
    Industry: Doctor's Office

    6210 E Hwy 290
    Suite 450
    AUSTIN
    TEXAS 78723
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    A way forward: a roundup of recent central bank decisions

    Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

    12:47, 22 March 2024

    Bank of Japan Preview: will the BOJ end negative interest rates?

    The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

    08:44, 18 March 2024

    People also watch

    XRP/USD

    0.49 Price
    -2.050% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    ETH/USD

    2,965.66 Price
    +0.460% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Gold

    2,404.55 Price
    +1.920% 1D Chg, %
    Long position overnight fee -0.0190%
    Short position overnight fee 0.0108%
    Overnight fee time 21:00 (UTC)
    Spread 0.39

    US100

    17,131.40 Price
    -2.020% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading